Related Experiment Videos
Insulin edema in diabetes mellitus associated with the 3243 mitochondrial tRNA(Leu(UUR)) mutation; case reports
Y Suzuki1, H Kadowaki, M Taniyama
1Saiseikai Central Hospital, Tokyo, Japan.
Abstract:
We encountered a patient with diabetes mellitus due to the 3243 mitochondrial tRNA mutation(DM-Mt3243), who developed insulin edema and hepatic dysfunction after starting insulin. Such a rare phenomenon was unlikely to be a fortuitous coincidence in mitochondrial diabetes, as none in 197 non-mutant NIDDM patients had same episode. Moreover, similar leg edema was noticed in another DM-Mt3243 patient, and other two DM-Mt3243 patients had leg edema which responded to coenzyme Q10. These observations suggest further a role of mitochondrial function on leg edema. The mechanism of his insulin edema may involve vasomotor changes induced by the rapidly glycemic control, because our case of insulin edema had a prominent increase of strong succinate dehydrogenase reactive vessels. Alternatively, myocardial dysfunction might have produced leg edema and hepatic dysfunction, because he had subclinical myocardial dysfunction, judged by imaging with beta-methyl-p-(123I)-iodophenyl-pentadecanoic acid. The third explanation is that a rapid improvement of glycemic control might have induced hepatic reoxygenation and the production of reactive oxygen species in the liver that contributed to cell damage. Thus, although we cannot draw definite conclusion, our experiences here suggest that mitochondrial dysfunction is important in the etiology of insulin edema.
Insights
Mitochondrial dysfunction may cause insulin edema in patients with diabetes mellitus due to the 3243 mitochondrial tRNA mutation (DM-Mt3243). This rare complication, linked to mitochondrial diabetes, warrants further investigation into its underlying mechanisms.
Area of Science:
- Endocrinology
- Genetics
- Metabolic Diseases
Background:
- Diabetes mellitus due to the 3243 mitochondrial tRNA mutation (DM-Mt3243) is a specific subtype of diabetes.
- Insulin therapy is a cornerstone in managing diabetes, but can have side effects.
Observation:
- A patient with DM-Mt3243 developed insulin edema and hepatic dysfunction after initiating insulin therapy.
- This adverse event was not observed in 197 non-mutant non-insulin-dependent diabetes mellitus patients.
- Similar leg edema was noted in another DM-Mt3243 patient and responded to coenzyme Q10 in two others.
Findings:
- The study suggests a potential role for mitochondrial dysfunction in the etiology of insulin edema.
- Possible mechanisms include vasomotor changes from rapid glycemic control, myocardial dysfunction, or hepatic reoxygenation injury.
- Increased succinate dehydrogenase reactivity in vessels was observed in the patient with insulin edema.
Implications:
- Mitochondrial dysfunction may be a significant factor in the development of insulin edema in specific diabetes populations.
- Further research is needed to elucidate the precise mechanisms linking mitochondrial health to insulin-induced complications.
- Coenzyme Q10 may be a potential therapeutic agent for managing leg edema in DM-Mt3243 patients.